Expert Opinion on Drug Delivery (1742-5247; 1744-7593) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug delivery.
Articles cover all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
The journal welcomes:
- Reviews covering delivery technologies, vehicles and devices; nanotechnology; novel formulations; the delivery of specific drug and therapeutic classes; gene/vaccine delivery strategies; modes of entry into the body and applications in certain diseases and disorders
- Technology evaluations reviewing a particular drug delivery technology
- Original research contributions are welcomed in the form of:
- Delivery technologies, vehicles, formulations and devices;
- The delivery of specific drugs and therapeutic classes;
- Modes of entry into the body and applications in certain diseases and disorders.
- Editorials commenting on the various drug delivery strategies which have been, and are being, explored
- Guidelines on the application of specific drug delivery systems, or in specific disease indications.
Please note that the journal does not publish case reports, case series, or animal studies.
The audience for the journal consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents.
Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;
Article Highlights – an executive summary of the author’s most critical points.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Publish in 3 weeks from submission with Accelerated Publication.
Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Drug Delivery, part of the Expert Collection brand.
Authors can choose to publish gold open access in this journal.
For any pre-submissions enquiries, please contact the Commissioning Editor.
EDITOR IN CHIEF
Prof. Uday Kompella, University of Colorado, Boulder, CO, USA
EDITORIAL ADVISORY BOARD
Prof. Javed Ali, Jamia Hamdard, New Delhi, India
Prof. Mansoor Amiji, Northeastern University, Boston, MA, USA
Prof. Sanjula Baboota, Jamia Hamdard, New Delhi, India
Prof. Nicholas Bodor, University of Florida, Gainesville, FL, USA
Prof. Anuj Chauhan, Colorado School of Mines, Golden, CO, USA
Prof. Pieter R Cullis, University of British Columbia, Vancouver, BC, Canada
Prof. Ryan F Donnelly, Queen's University Belfast, Northern Ireland, UK
Prof. Elias Fattal, University of Paris - South, Paris, France
Prof. Warren Finlay, University of Alberta, Edmonton, AB, Canada
Prof. Huile Gao, Sichuan University, Chengdu, China
Prof. Jianqing Gao, Zhejiang University, Zhejiang, China
Prof. Hideyoshi Harashima, Hokkaido University, Hokkaido, Japan
Prof. Yogeshvar Kalia, University of Geneva, Geneva, Switzerland
Dr. Lisa M Kaminskas, The University of Queensland, Queensland, Australia
Dr. Ajeet Kaushik, Florida Polytechnic University, Lakeland, FL, USA
Prof. Dimitrios Lamprou, Queen's University Belfast, Belfast, UK
Prof. Robert Langer, Massachusetts Institute of Technology, Cambridge, MA, USA
Prof. Ram I Mahato, University of Nebraska, Lincoln, NE, USA
Prof. Tamara Minko, Rutgers University, New Brunswick, NJ, USA
Dr. Pankaj Modi, CTT Pharma, Ottawa, ON, Canada
Prof. Ravin Narain: University of Alberta, Edmonton, AB, Canada
Dr. Seshadri Neervannan, Tarsus Pharmaceuticals, Irvine, CA, USA
Dr. Steve Newman, Scientific Consultant, Cambridge, England, UK
Dr. Derek O'Hagan, GSK Vaccines, Rockville, MD, USA
Prof. Abdel Omri, Laurentian University, Sudbury, ON, Canada
Prof. Jose Luis Pedraz, Paseo de la Universidad, Vitoria-Gasteiz, Spain
Prof. Nicholas Peppas, University of Texas, Austin, TX, USA
Prof. Michael A Repka, University of Mississippi, Lafayette County, MS, USA
Prof. Abraham Rubinstein, Hebrew University of Jerusalem, Jerusalem, Israel
Prof. Bruno Sarmento, University of Porto, Porto, Portugal
Dr. Alan Smith, Nutriband Inc, Atlanta, GA, USA
Dr. Thomas Tice, Evonik Degussa Corporation, Birmingham, AL, USA
Prof. Vladimir Torchilin, Northeastern University, Boston, MA, USA
Prof. Neeraj Vij, John Hopkins University, Baltimore, MD, USA
Expert Opinion on Drug Delivery is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})
![HRB Open Research is a platform for HRB-funded researchers to rapidly publish their research outputs in an open and accessible way.]({"type":"image" , "src" : "/sda/112432/HRB-KB.jpg"})